..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Early breast cancer Biomarker Guideline adherence Precision medicine...

... in EBC after NACT in this retrospective analysis. These results justify further investigation of CRP not as a predictive parameter for pCR but as a biomarker of long-term prognosis in EBC in prospective trials and may lead to therapeutic approaches with the aim of lowering CRP levels. hans...

.... PITX2 DNA methylation Therapy prediction Triple-negative breast cancer/neoplasms Anthracyclines Chemotherapy Biomarker Treatment outcome Tumor/genetics Homeodomain proteins/genetics Epigenetics is a breakthrough in patient-tailored medicine, delivering new biomarkers and therapeutic...

... mechanisms during treatment, cardiotoxicity, and a worse response to standard therapies lead to worse outcomes. Summary: Therefore, we investigated various biomarkers in breast cancer such as Her2 mutations, Her2 heterogeneity, HR, PIK3CA, PTEN, programmed death receptor ligand 1 (PD-L1), tumor-infiltrating...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Aromatase inhibitors Biomarker Breast cancer...

.... The translational effort and research of biomarkers conducted in these studies will be particularly addressed. © 2018 S. Karger GmbH, Freiburg Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any...

.... The use of prognostic biomarkers allows individualised breast cancer therapy but correct identification of patients who will benefit most from extended endocrine therapy is essential. Several multigene assays have been developed to determine the likelihood of overall recurrence but so far none exist...

... of invasion Biological factors Biomarker Breast cancer Disease management Invasive lobular carcinoma (ILC) of the breast is the most common ‘special' morphological subtype of breast cancer, comprising up to 15% of all cases. The cardinal feature of ILC is their inherently discohesive phenotype...

... approaches and opportunities to increase their efficacy will be summarized. Antibody therapy Biomarker Breast cancer Tumor marker Immunomodulation Immunotherapy Immune system © 2016 S. Karger GmbH, Freiburg Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Gene expression Prognostic markers Luminal breast cancer Biomarker Breast cancer Biomarker Mammakarzinom, luminales Genexpression Prognostische Marker...

.... Prognosis Cancer-associated fibroblasts Biomarker Gene Breast cancer 17 12 2012 2012 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic...

... neoplastic and non-neoplastic diseases, and that in cancer they originate mostly from the tumor. In this review, we discuss the potential application of CNA as a breast cancer biomarker for early diagnosis and patient evaluation. Most of the initial studies on CNA compared the levels of CNA in cancer...